{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Patent License to Nova Therapeutics LLC, a company having a place of business in Delaware, to practice the inventions embodied in the following patent applications:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/12/11/2014-29017.html","cfr_references":[],"citation":"79 FR 73601","comment_url":null,"comments_close_on":"2014-12-26","correction_of":null,"corrections":[],"dates":"Only written comments or applications for a license (or both) which are received by the NIH Office of Technology Transfer on or before December 26, 2014 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2014-29017","effective_on":null,"end_page":73601,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/12/11/2014-29017.xml","html_url":"https://www.federalregister.gov/documents/2014/12/11/2014-29017/prospective-grant-of-a-start-up-exclusive-patent-license-agreement-use-of-compounds-covered-by","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-29017?publication_date=2014-12-11","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-12-11/2014-29017/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":92,"last_updated":"2026-07-26 04:15:02 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-12-11/pdf/2014-29017.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-29017.pdf?1418219777","publication_date":"2014-12-11","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/12/11/2014-29017.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2015-01-12T19:21:14Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":73601,"subtype":null,"title":"Prospective Grant of a Start-Up Exclusive Patent License Agreement: Use of Compounds Covered by Patent Rights for Diagnosis of Human Thyroid Cancer Requiring FDA Premarket Approval or an Equivalent Authority Outside of the United States, and Treatment of Human Thyroid Cancer","toc_doc":"Use of Compounds Covered by Patent Rights for Diagnosis of Human Thyroid Cancer Requiring FDA Premarket Approval, etc.","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":79}